无骨水泥三锥度股骨柄假体十五年最低生存率的大规模随访研究
该回顾性研究纳入2000至2003年间376例连续全髋关节置换术(345例患者),使用三锥度股骨柄假体,评估至少15年(15-19年)的生存率及影像学与功能结果。
要点
- 三锥度股骨柄假体在全髋关节置换术中15年以上生存率优异,Kaplan-Meier生存率达97.70%。
- 无因无菌性松动行股骨柄翻修的病例,翻修原因包括假体周围骨折、假体周围感染和金属碎屑不良反应。
核心结论
- 三锥度股骨柄假体在全髋关节置换术中显示超过15年的优异生存率。
研究设计与样本
- 回顾性综述纳入2000至2003年间376例连续全髋关节置换术(345例患者),使用三锥度股骨柄假体,随访15-19年。
主要发现
- 45髋(11.9%)失访,20髋(5.31%)在15年截止随访前死亡,4髋(1.06%)早期拒绝随访,307髋(81.64%,276例患者)完成至少15年临床和影像学随访。
- 7例股骨柄(2.28%)翻修:4例因假体周围骨折,2例因假体周围感染,1例因锥部金属碎屑不良反应。
- 以任何原因行股骨柄翻修为终点的Kaplan-Meier生存率为97.70%;最差情况生存率(所有失访视为失败)为85.3%。
- 无因无菌性松动行股骨柄翻修的病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study reports the long-term outcomes of a metaphyseal fit-and-fill cementless femoral component in total hip arthroplasty (THA) with a follow-up of 15-19 years. METHODS: We conducted a retrospective review of 376 consecutive THAs (345 patients), using a triple tapered stem performed between 2000 and 2003 with a view to assessing survivorship and radiological and functional outcomes. Images were assessed for initial alignment, terminal osteolysis, or subsidence, while clinical outcomes were assessed using the St Michael's Hip Score. RESULTS: Forty-five (11.9%) hips were lost to follow-up, 20 (5.31%) had died before our 15-year cutoff follow-up, and 4 (1.06%) had declined follow-up early on, leaving 307 hips (81.64%, 276 patients) available for both clinical and radiological follow-up at a minimum of 15 years (range 15-19). The mean age at the time of operation was 49.6 years (range 19-71) and the cohort included 131 (42.67%) male and 145 (47.23%) female patients. Seven stems (2.28%) were revised: 4 due to periprosthetic fractures, 2 for periprosthetic joint infection, and 1 for adverse reaction to metal debris at the trunnion. The St Michael's Hip Score improved from 14.2 (range 9-23) preoperatively to 22.3 (range 13 to 25) at the last documented follow-up (P = .000). Kaplan-Meier survivorship with stem revision for any reason as the end point was 97.70%. Worst-case scenario Kaplan-Meier survivorship, where all lost to follow-up are considered as failures, was 85.3%. No stem was revised for aseptic loosening. CONCLUSION: This triple tapered stem in THA shows excellent survivorship beyond a minimum of 15 years.
引用
- Tyrpenou E, Khoshbin A, Mohammad S, et al. A Large-Scale Fifteen-Year Minimum Survivorship of a Cementless Triple Tapered Femoral Stem. J Arthroplasty. 2020. PMID: 32284208. doi:10.1016/j.arth.2020.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。